In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Biomet Sports Medicine Inc.

Division of Zimmer Biomet Holdings Inc.

Latest From Biomet Sports Medicine Inc.

Tissue Repair Start-Ups Fill Orthopedics' Gaps

Technologies for total joint repair, the backbone of the orthopedics industry, have occupied most of the development resources of orthopedic companies, but there are gaps in the continuum of care when it comes to tendon and ligament repair. ACL reconstruction and rotator cuff repair thus are attractive niches for start-ups, worth anywhere from $500 million to $1 billion. Soft tissue repair expertise is outside the core skill-sets of big ortho, but those companies have been willing to partner and acquire smaller innovative players. Today, the opportunity is even more attractive; sports medicine--the realm of soft tissue repair--enjoys an economic resiliency not seen in total joint replacement. Ligament tears more closely resemble trauma applications, which must be treated as soon as possible.

Medical Device

Deals Update April 2007

A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.

Medical Device

Arthroscopy for the Weekend Warrior

According to "US Markets for Arthroscopy Products," a recent report from Windhover/Medtech Insight that discusses in great detail the markets and products relating to the minimally invasive repair of injuries to the joints, there were more than 4 million arthroscopy procedures on the knees and shoulders in 2005. Overall, the US arthroscopy products market is worth over $640 million and it's projected to grow at an annual rate of approximately almost 5% to reach almost $1 billion in 2010.

Medical Device Platform Technologies

Pegasus Biologics Inc.

Pegasus is developing a process that allows it to tailor the mechanical properties of collagen implants according to the need for either graft longevity or rapid ingrowth. It can also terminally sterilize implants without changing these properties. It is initially targeting orthopedic soft tissue repair and ACL repair.

Medical Device Platform Technologies
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
    • Biomaterials
    • Implantable Devices
    • Surgical Equipment & Devices
  • Therapeutic Areas
  • Alias(es)
  • Arthrotek Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Zimmer Biomet Holdings Inc.
  • Senior Management
  • Joel Pratt, Pres.
  • Contact Info
  • Biomet Sports Medicine Inc.
    Phone: (800) 348-9500
    56 East Bell Dr.
    Warsaw, IN 46582